Coronavirus conserved viral protein

The term 'Coronavirus conserved viral protein' refers to a group of essential proteins that exhibit high sequence and structural homology across the Coronaviridae family, including SARS-CoV, MERS-CoV, and SARS-CoV-2 (Nature Communications, 2021). These proteins are primarily non-structural proteins (nsps) that constitute the viral replication-transcription complex, most notably the 3C-like protease (Mpro/NSP5), the RNA-dependent RNA polymerase (RdRp/NSP12), and the Helicase (NSP13) (UniProt P0DTD1). Because these proteins are critical for viral replication and are less prone to mutation than surface proteins like Spike, they are primary targets for broad-spectrum antiviral development (Science, 2021). Therapeutic agents such as nirmatrelvir and ensitrelvir target the conserved Mpro, while remdesivir and molnupiravir target the conserved RdRp (NEJM, 2022). Targeting these conserved sites is a key strategy for developing 'pan-coronavirus' therapies that remain effective against emerging variants and future outbreaks (Cell, 2020). However, drug development must address challenges such as potential drug-drug interactions and the risk of selecting for resistant viral strains (Nature Reviews Drug Discovery, 2022).

Other names

Conserved coronavirus proteinsPan-coronavirus targetsConserved non-structural proteinsMain protease (Mpro)RNA-dependent RNA polymerase (RdRp)Helicase (NSP13)Papain-like protease (PLpro)

Inhibition of essential viral enzymes such as the main protease (Mpro) and RNA-dependent RNA polymerase (RdRp) to block viral replication and transcription.